Table 1

Characteristics of patients at study entry according to group and sex (n=248)

Control group (n=127)Intervention group (n=121)
Women (n=87)Men (n=40)Women (n=72)Men (n=49)
Values are n (%).
Age
    18–291 (1.1)4 (10.0)1 (1.4)5 (10.2)
    30–395 (5.7)5 (12.5)7 (9.7)7 (14.3)
    40–4911 (12.6)6 (15.0)15 (20.8)12 (24.5)
    50–5923 (26.4)10 (25.0)20 (27.8)7 (14.3)
    60–6930 (34.5)11 (27.5)17 (23.6)8 (16.3)
    70+17 (19.5)4 (10.0)12 (16.7)10 (20.4)
Marital status
    Single (never married)1 (1.1)3 (7.5)5 (6.9)8 (16.3)
    Married44 (50.6)19 (47.5)40 (55.6)24 (49.0)
    Living with partner8 (9.2)5 (12.5)2 (2.8)1 (2.0)
    Single (divorced)9 (10.3)2 (5.0)5 (6.9)4 (8.2)
    Single (widowed)15 (17.2)5 (12.5)6 (8.3)3 (6.1)
    Missing10 (11.5)6 (15.0)14 (19.4)9 (18.4)
Stage of disease
    Local/locoregional70 (80.5)22 (55.0)61 (84.7)30 (61.2)
    Distant13 (14.9)13 (32.5)10 (13.9)15 (30.6)
    Missing4 (4.6)5 (12.5)1 (1.4)4 (8.2)
Cancer diagnosis
    Breast53 (60.9)043 (59.7)0
    Gastrointestinal7 (8.0)10 (25.0)6 (8.3)9 (18.4)
    Germinal cell010 (25.0)014 (28.6)
    Head and neck3 (3.4)4 (10.0)6 (8.3)7 (14.3)
    Bladder and kidney07 (17.5)4 (5.6)7 (14.3)
    Ovarian and cervix15 (17.2)08 (11.1)0
    Sarcoma4 (4.6)5 (12.5)2 (2.8)5 (10.2)
    Malignant melanoma1 (1.1)1 (2.5)1 (1.4)5 (10.2)
    Brain2 (2.3)01 (1.4)0
    Lung1 (1.1)2 (5.0)1 (1.4)2 (4.1)
    Miscellaneous1 (1.1)1 (2.5)00
Treatment intention
    Curative71 (81.6)23 (57.5)64 (88.9)35 (71.4)
    Palliative9 (10.3)11 (27.5)6 (8.3)10 (20.4)
    Missing7 (8.0)6 (15.0)2 (2.8)4 (8.2)
Allocation of patients to GP practices
    Practices with one patient (n=162)7488
    Practices with two patients (n=28)3224
    Practices with three patients (n=7)129
    Practice with four patients (n=1)40
    Practice with five patients (n=1)50